Fortrea Development Limited is a leading clinical research organization (CRO) specializing in patient-focused clinical trial solutions. Established in 1986, Fortrea operates globally and is currently active with a significant international presence. The company’s core business revolves around accelerating the clinical development process for pharmaceutical and biotechnology companies. Fortrea’s expertise lies in providing comprehensive services encompassing patient recruitment, data management, clinical protocol design, and regulatory support. They are recognized as a leading provider within the CRO sector, focusing intently on optimizing trial efficiency and maximizing success rates. The organization’s strategic focus is on driving innovation and bringing novel therapies to patients who stand to benefit most. Fortrea’s international network allows them to strategically partner with clients across various geographies. As a CRO, Fortrea utilizes a variety of specialized services, including patient-centric clinical trial design and execution. The company’s workforce includes a significant number of Visa holders, indicating a commitment to global talent and operations. The organization’s SIC codes include -72190, reflecting its involvement in research and experimental development within the natural sciences and engineering fields.

Fortrea Development Limited is a leading clinical research organization (CRO) specializing in patient-focused clinical trial solutions. Established in 1986, Fortrea operates globally and is currently active with a significant international presence. The company’s core business revolves around accelerating the clinical development process for pharmaceutical and biotechnology companies. Fortrea’s expertise lies in providing comprehensive services encompassing patient recruitment, data management, clinical protocol design, and regulatory support. They are recognized as a leading provider within the CRO sector, focusing intently on optimizing trial efficiency and maximizing success rates. The organization’s strategic focus is on driving innovation and bringing novel therapies to patients who stand to benefit most. Fortrea’s international network allows them to strategically partner with clients across various geographies. As a CRO, Fortrea utilizes a variety of specialized services, including patient-centric clinical trial design and execution. The company’s workforce includes a significant number of Visa holders, indicating a commitment to global talent and operations. The organization’s SIC codes include -72190, reflecting its involvement in research and experimental development within the natural sciences and engineering fields.